GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

DNAPrint Genomics DNAG · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2006

Revenue

$2.4m

FY2006FY2006

Net income

−$12.3m

FY2006FY2006

Free cash flow

−$6.2m

FY2006FY2006

Shareholders' equity

−$3.7m

FY2006FY2006

Income statement

Fiscal years

FY2006
Revenue$2.4m
Gross profit$754,068
Research and development$6.4m
Operating income−$8.9m
Net income−$12.3m
Diluted earnings per share-0.03

Balance sheet

At each fiscal year end

FY2006
Total assets$10.3m
Cash and short-term investments$8.5m
Total liabilities$14.0m
Debt$7.3m
Shareholders' equity−$3.7m
Shares outstanding430m

Cash flow

Fiscal years

FY2006
Cash from operations−$5.8m
Capital spending−$391,445
Free cash flow−$6.2m

Latest quarters

By quarter end

Sept 2007Jun 2007Mar 2007Dec 2006Sept 2006Jun 2006Mar 2006Dec 2005
Revenue$227,562$476,987$701,013$525,646$651,753$577,202$678,399$369,033
Gross profit−$6,588$85,736$186,315$180,906$218,178$209,762$145,222$73,683
Operating income$1.7m$1.5m$1.4m$1.7m$2.7m$1.8m$2.6m$1.5m
Net income−$1.9m−$1.7m$2.9m−$3.9m−$3.3m−$2.4m−$2.8m−$4.9m
Diluted earnings per share-0.00-0.000.00-0.01-0.01-0.01-0.01-0.03
Cash from operations−$1.0m−$1.0m−$1.0m—−$1.0m−$2.0m−$2.0m—
Total assets$3.1m$4.9m$6.7m$10.3m$4.4m$5.6m$5.0m$6.3m
Cash and short-term investments$134,347$507,966$4.9m$8.5m$110,789$1.3m$639,425$1.8m
Debt$5.3m$5.6m$6.0m$7.3m$6.7m$6.5m$3.4m$1.1m
Shareholders' equity−$8.4m−$7.0m−$5.8m−$3.7m−$6.0m−$3.0m−$1.3m−$4.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue50.8%179.0%—
Net income16.6%36.6%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin29.1%31.4%32.5%—
Operating margin-364.8%-76.1%22.3%—
Net margin-568.0%-626.3%-708.8%—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%33%0%3650%0%900%2900%100%300%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 20-to-1 reverse split · 12 Jul 2005

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.